Your browser doesn't support javascript.
loading
The High Mobility Group A1 (HMGA1) gene is highly overexpressed in human uterine serous carcinomas and carcinosarcomas and drives Matrix Metalloproteinase-2 (MMP-2) in a subset of tumors.
Hillion, Joelle; Roy, Sujayita; Heydarian, Mohammad; Cope, Leslie; Xian, Lingling; Koo, Michael; Luo, Li Z; Kellyn, Kathleen; Ronnett, Brigitte M; Huso, Tait; Armstrong, Deborah; Reddy, Karen; Huso, David L; Resar, L M S.
Afiliación
  • Hillion J; Hematology Division, The Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Roy S; Hematology Division, The Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Heydarian M; Department of Biologic Chemistry, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Cope L; Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Xian L; Hematology Division, The Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Koo M; Hematology Division, The Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Luo LZ; Hematology Division, The Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Kellyn K; Pathobiology Graduate Program, The Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Molecular and Comparative Pathobiology, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Ronnett BM; Pathobiology Graduate Program, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Huso T; Hematology Division, The Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Armstrong D; Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Reddy K; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Biologic Chemistry, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Huso DL; Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Molecular and Comparative Pathobiology, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Resar LMS; Hematology Division, The Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, United St
Gynecol Oncol ; 141(3): 580-587, 2016 06.
Article en En | MEDLINE | ID: mdl-27001612

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Uterinas / Carcinosarcoma / Cistadenocarcinoma Seroso / Metaloproteinasa 2 de la Matriz / Proteína HMGA1a Límite: Animals / Female / Humans / Male Idioma: En Revista: Gynecol Oncol Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Uterinas / Carcinosarcoma / Cistadenocarcinoma Seroso / Metaloproteinasa 2 de la Matriz / Proteína HMGA1a Límite: Animals / Female / Humans / Male Idioma: En Revista: Gynecol Oncol Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos